These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 18693083)

  • 1. Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophrenia.
    Dean B; Crossland N; Boer S; Scarr E
    Schizophr Res; 2008 Sep; 104(1-3):185-97. PubMed ID: 18693083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
    Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
    Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.
    Muguruza C; Moreno JL; Umali A; Callado LF; Meana JJ; González-Maeso J
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):852-64. PubMed ID: 23176747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical serotonin7, 1D and 1F receptors: effects of schizophrenia, suicide and antipsychotic drug treatment.
    Dean B; Pavey G; Thomas D; Scarr E
    Schizophr Res; 2006 Dec; 88(1-3):265-74. PubMed ID: 16916599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia.
    Rasmussen H; Erritzoe D; Andersen R; Ebdrup BH; Aggernaes B; Oranje B; Kalbitzer J; Madsen J; Pinborg LH; Baaré W; Svarer C; Lublin H; Knudsen GM; Glenthoj B
    Arch Gen Psychiatry; 2010 Jan; 67(1):9-16. PubMed ID: 20048218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophrenia.
    Pralong D; Tomaskovic-Crook E; Opeskin K; Copolov D; Dean B
    Schizophr Res; 2000 Jul; 44(1):35-45. PubMed ID: 10867310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of serotonin 5-HT(2A) receptors in the human cerebellum and alterations in schizophrenia.
    Eastwood SL; Burnet PW; Gittins R; Baker K; Harrison PJ
    Synapse; 2001 Nov; 42(2):104-14. PubMed ID: 11574947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower cortical serotonin 2A receptors in major depressive disorder, suicide and in rats after administration of imipramine.
    Dean B; Tawadros N; Seo MS; Jeon WJ; Everall I; Scarr E; Gibbons A
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):895-906. PubMed ID: 24495390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2A and muscarinic receptors in schizophrenia: a postmortem study.
    Matsumoto I; Inoue Y; Iwazaki T; Pavey G; Dean B
    Neurosci Lett; 2005 May; 379(3):164-8. PubMed ID: 15843056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family history of alcoholism is associated with lower 5-HT2A receptor binding in the prefrontal cortex.
    Underwood MD; Mann JJ; Huang YY; Arango V
    Alcohol Clin Exp Res; 2008 Apr; 32(4):593-9. PubMed ID: 18241316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1.
    Dean B; Soulby A; Evin GM; Scarr E
    Schizophr Res; 2008 Dec; 106(2-3):229-36. PubMed ID: 18790604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
    Burnet PW; Eastwood SL; Harrison PJ
    Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin 5-HT
    García-Bea A; Miranda-Azpiazu P; Muguruza C; Marmolejo-Martinez-Artesero S; Diez-Alarcia R; Gabilondo AM; Callado LF; Morentin B; González-Maeso J; Meana JJ
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1453-1463. PubMed ID: 31734018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex.
    Dean B; Hussain T; Hayes W; Scarr E; Kitsoulis S; Hill C; Opeskin K; Copolov DL
    J Neurochem; 1999 Apr; 72(4):1593-9. PubMed ID: 10098866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors.
    Steward LJ; Kennedy MD; Morris BJ; Pratt JA
    Neuropharmacology; 2004 Sep; 47(4):527-37. PubMed ID: 15380371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia--a postmortem study.
    Kang K; Huang XF; Wang Q; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):867-71. PubMed ID: 19389456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.
    Suzuki H; Gen K; Inoue Y
    J Psychopharmacol; 2013 Apr; 27(4):396-400. PubMed ID: 23427194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo serotonin 5-HT(2A) receptor occupancy and quetiapine.
    Jones HM; Travis MJ; Mulligan R; Visvikis D; Gacinovic S; Ell PJ; Kerwin RW; Pilowsky LS
    Am J Psychiatry; 2000 Jan; 157(1):148. PubMed ID: 10618043
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased cerebral cortex and liver 5-HT2A receptor gene expression and enhanced ALDH activity in ethanol-treated rats and hepatocyte cultures.
    George AK; Paul J; Kaimal SB; Paulose CS
    Neurol Res; 2010 Jun; 32(5):510-8. PubMed ID: 20501057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.
    Crook JM; Tomaskovic-Crook E; Copolov DL; Dean B
    Am J Psychiatry; 2001 Jun; 158(6):918-25. PubMed ID: 11384900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.